November 11, 2024

The Arkansas Children’s Nutrition Center (ACNC) is celebrating three decades of discoveries that have helped children around the world grow up healthier and stronger.

ACNC was established in 1994 through congressional appropriation of USDA funding and today has a portfolio of large-scale studies exploring how maternal diet, physical activity, and early feeding practices influence a child’s growth and development.

November 4, 2024

CHI St. Vincent has appointed Chief Nurse Executive Angie Longing as president of CHI St. Vincent Morrilton. In her new position, Longing will continue to serve as chief nurse executive for the CHI St. Vincent Arkansas market. Longing moves into the role after former CHI St. Vincent Morrilton President Bubba Arnold retired in late September. 

November 4, 2024

This article by Tess Vrbin was published in the Arkansas Advocate on October 28, 2024

Roughly 60% of postpartum Arkansans who qualified for Medicaid between July 1 and Sept. 30 retained some form of Medicaid coverage 60 days after giving birth, Arkansas Department of Human Services officials told a legislative panel Monday.

DHS found that most of the remaining 40% were ineligible for Medicaid by 60 days postpartum, Secretary Kristi Putnam and state Medicaid Director Janet Mann told the Joint Public Health, Welfare and Labor committee.

November 4, 2024

The Nabholz Charitable Foundation has donated
$1 million towards Arkansas Children’s Hospital’s expansion project.

Nabholz has been a long-standing partner of Arkansas Children's since the 1970s, when founder Bob Nabholz joined the Arkansas Children’s Board of Directors. More than 50 years later, they have consistently championed children through philanthropic support and volunteer service. In addition, four of Nabholz' executive team members have served as board members.

October 28, 2024

The National Institutes of Health (NIH) has awarded $2.9 million to Arkansas Children’s Research Institute (ACRI) to examine how a critical therapy for patients with cystic fibrosis (CF) might become even more effective at treating the genetic respiratory illness.